Reduced Motility Related Protein-1 (MRP-1/CD9) Gene Expression as a Factor of Poor Prognosis in Non-Small Cell Lung Cancer

Cancer Research

Volumn 55, Issue 24, 1995, Pages 6040-6044

  Higashiyama, Masahiko ^a   Kodama, Ken ^a   Doi, Osamu ^a   Taki, Toshihiko ^b,c   Ieki, Yoshiaki ^b   Adachi, Masashi ^b   Huang, C L ^b   Miyake, Masayuki ^b  

^a CENTER FOR ADULT DISEASES   (Japan)

^b Kitano Hospital   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD; BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; DNA PRIMERS; FEMALE; GENE EXPRESSION; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGE; MOLECULAR SEQUENCE DATA; PROGNOSIS; RNA, MESSENGER; RNA, NEOPLASM; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS;

EID: 0028803507     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Miyake, M, Koyama, M., Seno, M., and Ikeyama, S. Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J. Exp. Med., 174: 1347-1354. 1991.
2. Boucheix, C., Benoit, P., Frachet, P., Billard, M., Worthington, R. E., Gagnon, J., and Uzan, G. Molecular cloning of the CD9 antigen. J. Biol. Chem., 266: 117-122, 1991.
3. Lanza, F., Wolf, D., Fox, C. F., Kieffer, N., Seyer, J. M., Fried, V. A., Coughlin, S. R., Phillips, D. R., and Jennings, L. K. cDNA cloning and expression of platelet p24/CD9. J. Biol. Chem., 266: 10638-10645, 1991.
4. Wright, M. D., and Tomlinson, M. G. The ins and outs of the transmembrane 4 superfamily. Immunol. Today, 15: 588-594, 1994.
5. Griffith, L., Slupsky, J., Seehafer, J., Boshkov, L., and Shaw, A. R. E. Platelet activation by immobilized monoclonal antibody: evidence for a CD9 proximal signal. Blood, 78: 1753-1759, 1991.
6. Yatomi, Y., Ozaki, Y., Satoh, K., and Kume, S. Anti-CD9 monoclonal antibody elicits staurosporine inhibitable phosphatidylinositol 4,5-bisphosphate hydrolysis, phosphatidylinositol 3,4-bisphosphate synthesis, and protein-tyrosine phosphorylation in human platelets. FEBS Lett., 322: 285-290, 1993.
7. Ozaki, Y., Matsumoto, Y., Yatomi, Y., Higashihara, M., and Kume, S. Two-step mobilization of arachidonic acid in platelet activation induced by low concentrations of TP82, a monoclonal antibody against CD9 antigen. Eur. J. Biochem., 199: 347-354, 1991.
8. Ikeyama, S., Koyama, M., Yamaoko, M., Sasada, R., and Miyake, M. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J. Exp. Med., 177: 1231-1237, 1993.
9. Miyake, M., Nakano, K., Ieki, Y., Adachi, M., Huang, C.-L., Itoi, S., Koh, T., and Taki, T. Motility Related Protein-1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res., 55: 4127-4131, 1995.
10. Hermanek, P., and Sobin, L. H. (eds.). TNM Classification of Malignant Tumours. Ed. 4, pp. 75-80. Berlin: Springer-Verlag, 1987.
11. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156– 159, 1987.
12. Chelly, J., Kaplan, J-C., Maire, P., Gautron, S., and Kahn, A. Transcription of the dystrophin gene in human muscle and non-muscle tissues. Nature (Lond.), 333: 858-860, 1988.
13. Nakajima-lijima, S., Hamada, H., Reddy, P., and Kakunaga, T. Molecular structure of the human cytoplasmic β-actin gene: interspecies homology of sequences in the introns. Proc. Natl. Acad. Sci. USA, 82: 6133-6137, 1985.
14. Scheck, A. C., Mehta, B. M., Beikman, M. K., and Shapiro, J. R. BCNU-resistant human glioma cells with overepresentation of chromosomes 7 and 22 demonstrate increased copy number and expression of platelet-derived growth factor genes. Genes Chromosomes & Cancer, 8: 137-148, 1993.
15. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
16. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
17. Cox, D. R. Regression models and life-tables. J. R. Stat. Soc. B, 34: 187-220, 1972.
18. Horio, Y., Takahashi, T., Kuroishi, T., Hibi, K., Suyama, M., Niimi, T., Shimokata, K., Yamakawa, K., Nakamura, Y., Ueda, R., and Takahashi, T. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer. Res., 53: 1-4, 1993.
19. Bains, M. S. Surgical treatment of lung cancer. Chest, 100: 826-837, 1991.
20. Bunn, P. A., Zandwijk, N. V., Pastorino, U., Aisner, J., Alberto, P., Arriagada, R., Carney, D., Cornis, R., Dittrich, C., Gatzemeier, U., Ginsberg, R., Greco, F. A., Hansen, H. H., Harper, P., Henriksson, R., Huber, H., Klener, P., LeChevalier, T., Lewensohn, R., Murray, N., Niederle, N., Postmus, P., Rosell, R., Scagliotti, G., Sculier, J. P., Splinter, T., Stahel, R., Symann, M., Thatcher, N., Tonato, M., and Turrisi, A. First Euro-American forum on lung cancer treatment. Eur. J. Cancer, 30A: 1-4, 1994.
21. Mountain, C. F. A new international staging system for lung cancer. Chest, 89: 225S-233S, 1986.
22. Roth, J. A., Fossella, F., Komaki, R., Ryan, M. B., Putnam, J. B., Jr., Lee, J. S., Dhingra, H., Caro, L. D., Chasen, M., McGavran, M., and Atkinson, E. N. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J. Natl. Cancer Inst., 86: 673-680, 1994.
23. Kirn, D. H., Lynch, T. J., Mentzer, S. J., Lee, T. H., Strauss, G. M., Elias, A. D., Skarin, A. T., and Sugarbaker, D. J. Multimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancer. J. Thorac. Cardiovasc. Surg., 106: 696-702, 1993.
24. Martini, N., Kris, M. G., Flehinger, B. J., Gralla, R. J., Bains, M. S., Burt, M. E., Heelan, R., McCormack, P. M., Pisters, K. M. W., Rigas, J. R., Rusch, V. W., and Ginsberg, R. J. Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann. Thorac. Surg., 55: 1365-1374, 1993.
25. Muss, H. B., Thor, A. D., Berry, D. A., Kute, T., Liu, E. T., Koerner, F., Cirrincione, C. T., Budman, D. R., Wood, W. C., Barcos, M., and Henderson, I. C. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N. Engl. J. Med., 330: 1260-1266, 1994.
26. Slebos, R. J. C., Kibbelaar, R. E., Dalesio, O., Kooistra, A., Stam, J., Meijer, C. J. L. M., Wagenaar, S. S., Vanderschueren, R. G. J. R. A., Zandwijk, N. V., Mooi, W. J., Bos, J. L., and Rodenhuis, S. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N. Engl. J. Med., 323: 561-565, 1990.
27. Rosell, R., Li, S., Skacel, Z., Mate, J. L., Maestre, J., Canela, M., Tolosa, E., Armengol, P., Barnadas, A., and Ariza, A. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients. Oncogene, 8: 2407-2412, 1993.
28. Rosell, R., Gomez-Codina, J., Camps, C., Maestre, J., Padille, J., Canto, A., Mate, J. L., Li, S., Roig, J., Olazabal, A., Canela, M., Ariza, A., Skacel, Z., Morera-Prat, J., and Abad, A. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N. Engl. J. Med., 330: 153-158, 1994.
29. Mitsudomi, T., Oyama, T., Kusano, T., Osaki, T., Nakanishi, R., and Shirakusa, T. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. J. Natl. Cancer Inst., 85: 2018-2023, 1993.
30. Miyake, M., Taki, T., Hitomi, S., and Hakomori, S. Correlation of expression of H/Ley/Leb antigens with survival in patients with carcinoma of the lung. N. Engl. J. Med., 327: 14-18, 1992.
31. Ogawa, J., Sano, A., Inoue, H., and Koide, S. Expression of Lewis-related antigen and prognosis in stage I non-small cell lung cancer. Ann. Thorac. Surg., 59: 412-415, 1995.
32. Classon, B. J., Williams, A. F., Willis, A. C., Seed, B., and Stamenkovic, I. The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen. J. Exp. Med., 169: 1497-1502, 1989.
33. Amiot, M. Identification and analysis of cDNA clones encoding CD53: a pan-leukocyte antigen related to membrane transport proteins. J. Immunol., 145: 4322– 4325, 1990.
34. Hotta, H., Ross, A. H., Huebner, K., Isobe, M., Wendeborn, S., Chao, M. V., Ricciardi, R. P., Tsujimoto, Y., Croce. C. M., and Koprowski, H. Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res., 48: 2955-2962, 1988.
35. Oren, R., Takahashi, S., Doss, C., Levy, R., and Levy, S. TAPA-1, the target of an antiproliferative antibody, defines, a new family of transmembrane proteins. Mol. Cell. Biol., 10: 4007-4015, 1990.
36. Gaugitsch, H. W., Hofer, E., Huber, N. E., Schnabl, E., and Baumruker, T. A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23. Eur. J. Immunol., 21: 377-383, 1991.
37. Szala, S., Kasai, Y., Steplewski, Z., Rodeck, U., Koprowski, H., and Linnenbach, A. J. Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens. Proc. Natl. Acad. Sci. USA, 87: 6833-6837, 1990.
38. Wright, M. D., Henkle, K. J., and Mitchell, G. F. An immunogenic Mr 23,000 integral membrane protein of Schistosoma mansoni worms that closely resembles a human tumor-associated antigen. J. Immunol., 144: 3195-3200, 1990.
39. Horejsi, V., and Vlcek, C. Novel structurally distinct family of leukocyte surface glycoproteins including CD9, CD37, CD53 and CD63. FEBS Lett., 288: 1-4, 1991.
40. Dong, J-T., Lamb, P. W., Rinker-Schaeffer, C. W., Vukanovic, J., Ichikawa, T., Isaacs, J. T., and Barrett, J. C. KAI-1, a metastasis suppressor gene for prostate cancer on human chromosome 11 p11.2. Science (Washington DC), 268: 884-886, 1995.